The brain is a recognized target of iron deposition. This process is enhanced by the presence of obesity and hyperglycemia and impacts cognitive functions. There is evidence suggesting that the gut microbiota composition modulates this process. It has been proposed that microRNAs are mediators in the dialogue between the composition and functionality of the intestinal microbiota and increased iron deposition in the brain. The hypothesis is that circulating microRNAs are associated with parameters of cognitive dysfunction, gut microbiota, brain iron content, glucose levels, and physical activity in subjects with and without obesity. The study includes both a cross-sectional (comparison of subjects with and without obesity) and a longitudinal design (evaluation one year after weight loss induced by bariatric surgery or by diet in patients with obesity) to evaluate the associations between circulating microRNAs, continuous glucose monitoring, brain iron content (by magnetic resonance), cognitive function (by means of cognitive tests), physical activity (measured by activity and sleep tracker device) and the composition of the microbiota, evaluated by metagenomics.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Concentration of advanced glycation end products (AGE) receptor agonists.
Timeframe: 30 months
Glycemic variability.
Timeframe: 30 months
The percentage of time in glucose target range (glucose level 100mg/dl-125mg/dl)
Timeframe: 30 months
The glycaemic risk measured with low blood glucose index (LBGI)
Timeframe: 30 months
The glycaemic risk measured with high blood glucose index (HBGI)
Timeframe: 30 months
The glycaemic variability measured with mean amplitude of glycaemic excursions (MAGE)
Timeframe: 30 months
Minutes light sleep
Timeframe: 30 months
Minutes deep sleep
Timeframe: 30 months
Minutes rapid eye movement (REM)
Timeframe: 30 months